Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,944
Award facts
- Contract value 100% obligated
- $44,943.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,943.72 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation and represents a discrete pharmaceutical supply requirement under DMS Pharmaceutical Group's broader prime vendor contract. The award falls under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Department of Defense acquisition strategy designed to ensure reliable pharmaceutical supply chains for military healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award indefinite delivery contract (SPE2DR) under the PPV-G GEN V framework, awarded in November 2025 with a $499,999,999 ceiling value and completion date of December 31, 2036. The company supplies a comprehensive range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Defense Department healthcare operations globally. As one of multiple regional prime vendor contractors under this strategic acquisition vehicle, DMS Pharmaceutical Group has demonstrated consistent performance across numerous delivery orders, positioning it as a critical supplier within the federal military pharmaceutical supply chain with no identified subcontractors.
Quick answers
Who was awarded contract SPE2DU26FEMRC?
SPE2DU26FEMRC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DU26FEMRC worth?
The government has obligated $44,944 on SPE2DU26FEMRC.
Is contract SPE2DU26FEMRC an order under another contract?
Yes. SPE2DU26FEMRC is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRC competed?
The extent of competition for SPE2DU26FEMRC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award